Cover Image
市場調查報告書

栓塞保護裝置的全球市場:2016∼2020年

Global Embolic Protection Devices Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 364914
出版日期 內容資訊 英文 84 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
栓塞保護裝置的全球市場:2016∼2020年 Global Embolic Protection Devices Market 2016-2020
出版日期: 2016年07月19日 內容資訊: 英文 84 Pages
簡介

血管若形成斑塊便可能引起冠狀動脈疾病。這是由於血管很細,正常的血流大,恐怕導致缺血性中風。治療可用導管不過,斑塊乘著血流到達腦的話,會中風或死亡。為了防止發生,使用栓塞保護裝置,除去血塊。全球栓塞保護裝置市場,預計2016∼2020年以9.58%的年複合成長率擴大。

本報告提供全球栓塞保護裝置市場相關調查,市場成長預測,各地區趨勢,市場趨勢與課題,主要供應商的競爭趨勢等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 栓塞保護裝置的全球市場:各產品市場分類

  • 阻塞設備
  • 末梢過濾器設備

第7章 栓塞保護裝置的全球市場:各治療市場分類

  • 冠狀動脈疾病治療
  • 頸動脈疾病治療
  • 週邊動脈疾病治療

第8章 栓塞保護裝置的全球市場:各終端用戶市場分類

  • ASC
  • 醫院
  • 診療所

第9章 栓塞保護裝置的全球市場:各地區分類

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第10章 栓塞保護裝置的全球市場:促進要素

  • 心臟病的發病率和PCI的引進
  • PCI設備研究外包CRO
  • 微企業為了進入市場的創業投資
  • 使用改良的醫療用影像的微創手術

第11章 促進要素的影響

第12章 栓塞保護裝置的全球市場:課題

  • 支架術的成本高
  • 產品回收
  • 產品差異化的不足使利益縮小

第13章 促進要素與課題的影響

第14章 栓塞保護裝置的全球市場:趨勢

第15章 供應商環境

  • 競爭模式

第16章 主要供應商分析

  • Abbott Laboratories
  • Boston Scientific
  • Cardinal Health
  • Medtronic
  • 其他值得注意的供應商

第17章 附錄

第18章 關於Technavio

目錄
Product Code: IRTNTR9932

About Embolic Protection Devices

The formation of plaque in the blood vessels can cause coronary artery disease (CAD). The disease causes narrowing of the blood vessels, which interrupts normal blood flow and may lead to ischemic stroke. Physicians may implant catheters along with stents to treat the disease; however, the procedure can lead to embolism or disruption of plaque. The plaque debris may pass into the blood flow through the carotid artery to reach the brain, which can lead to stroke and death. To prevent this, physicians use embolic protection devices to collect and remove the debris from the blood vessels while performing angioplasty and stenting procedures.

Technavio's analysts forecast the global embolic protection devices market to grow at a CAGR of 9.58% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global embolic protection devices market for 2016-2020. To calculate the market size, we consider revenue generated from the sales of embolic protection devices used for capturing and removing embolic debris in the blood lodged during stenting or angioplasty.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Embolic Protection Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Laboratories
  • Boston Scientific
  • Cardinal Health
  • Medtronic

Other Prominent Vendors

  • Abiomed
  • AdvanSource Biomaterials
  • AGA Medical
  • Allium Medical Solutions
  • AngioDynamics
  • Angioslide
  • Atrium Medical
  • Biophan Technologies
  • Biosense Webster
  • Cardiac Science
  • CardiacAssist
  • Cardica
  • Cardio Flow
  • Claret Medical
  • Contego Medical
  • Cook Group
  • Edward Lifesciences
  • Innovative Cardiovascular Solutions
  • Keystone Heart
  • Transverse Medical

Market driver

  • Incidence of cardiac diseases and adoption of PCI
  • For a full, detailed list, view our report

Market challenge

  • High cost of stenting
  • For a full, detailed list, view our report

Market trend

  • Integrated technologies by small companies for market penetration
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights
  • Embolic protection devices: An overview

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • Global occlusion devices market
  • Global distal filter devices market

PART 07: Market segmentation by treatment procedure

  • Global embolic protection devices market for coronary artery treatment
  • Global embolic protection devices for carotid artery treatment
  • Global embolic protection devices for peripheral artery treatment

PART 08: Market segmentation by end-users

  • ASCs
  • Hospitals
  • Physicians' offices

PART 09: Geographical segmentation

  • Embolic protection devices market in Americas
  • Embolic protection devices market in EMEA
  • Embolic protection devices market in APAC

PART 10: Market drivers

  • Incidence of cardiac diseases and adoption of PCI
  • Outsourcing PCI device research to CROs
  • Venture capitals for market entry of start-ups
  • Minimally invasive procedures with improved medical imaging

PART 11: Impact of drivers

PART 12: Market challenges

  • High cost of stenting
  • Product recalls
  • Lack of product differentiation leading to marginal profits

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Integrated technologies by small companies for market penetration
  • Emergence of digital cath-labs in hospitals
  • Transforming marketing and sales strategies for embolic protection devices

PART 15: Vendor landscape

  • Competitive scenario

PART 16: Major vendors

  • Abbott Laboratories
  • Boston Scientific
  • Cardinal Health
  • Medtronic
  • Other prominent vendors

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Embolic protection devices: Clinical studies with positive results
  • Exhibit 03: Global embolic protection devices market: New entrants
  • Exhibit 04: Scope of embolic protection devices in various regions 2016-2020
  • Exhibit 05: Global embolic protection devices market: Impact assessment
  • Exhibit 06: Global embolic protection devices market 2015-2020 ($ millions)
  • Exhibit 07: Global embolic protection devices market: Metrics analysis
  • Exhibit 08: Five forces analysis
  • Exhibit 09: Global embolic protection devices market segmentation by product 2015
  • Exhibit 10: Global balloon occlusion devices market: Metrics analysis
  • Exhibit 11: Global distal filter devices market: Metrics analysis
  • Exhibit 12: Global embolic protection devices market segmentation by treatment procedure 2015
  • Exhibit 13: Global embolic protection devices market for coronary artery treatment: Market overview
  • Exhibit 14: Global embolic protection devices for carotid artery treatment: Market overview
  • Exhibit 15: Global embolic protection devices for peripheral artery treatment: Market overview
  • Exhibit 16: Global embolic protection devices market segmentation by end-user 2015
  • Exhibit 17: Comparison of reimbursement for ASCs, hospital outpatient departments, and physicians' offices in US
  • Exhibit 18: Coronary angioplasty same day basis procedure in hospitals and ASCs in Europe
  • Exhibit 19: Global embolic protection devices market segmentation by geography 2015
  • Exhibit 20: Global embolic protection devices market segmentation by geography 2020
  • Exhibit 21: Global embolic protection devices market segmentation by geography 2015-2020
  • Exhibit 22: Global embolic protection devices market segmentation by geography 2015-2020 ($ millions)
  • Exhibit 23: Number of coronary angiography procedures in few countries in Americas 2013
  • Exhibit 24: Embolic protection devices market in Americas 2015-2020 ($ millions)
  • Exhibit 25: Embolic protection devices market in the Americas: Metrics analysis for various countries
  • Exhibit 26: Implements amended in ACA in US
  • Exhibit 27: Impact of ACO and ACA on embolic protection devices
  • Exhibit 28: Embolic protection devices in EMEA: Market overview
  • Exhibit 29: Number of coronary revascularization procedures per 100,000 people in various countries in EMEA 2013
  • Exhibit 30: Number of coronary angiography procedures in various countries in EMEA 2006 and 2013
  • Exhibit 31: Embolic protection devices market in EMEA 2015-2020 ($ millions)
  • Exhibit 32: Embolic protection devices market in APAC: Market overview
  • Exhibit 33: Embolic protection devices market in APAC 2015-2020 ($ millions)
  • Exhibit 34: CROs that helped companies receive regulatory approvals for PCI devices
  • Exhibit 35: New market entrants
  • Exhibit 36: Impact of drivers
  • Exhibit 37: Product recalls: Embolic protection devices and stents
  • Exhibit 38: Impact of drivers and challenges
  • Exhibit 39: Some advanced embolic protection devices
  • Exhibit 40: Marketing and sales strategies of large and small companies
  • Exhibit 41: Global embolic protection devices market: Competitive landscape analysis 2015
  • Exhibit 42: Global market penetration of various companies 2015
  • Exhibit 43: Abbott Laboratories: Metrics analysis
  • Exhibit 44: Boston Scientific: Metrics analysis
  • Exhibit 45: Cardinal Health: Metrics analysis
  • Exhibit 46: Medtronic: Metrics analysis
  • Exhibit 47: Other prominent vendors
Back to Top